Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes. - Christiansen,J.S.; Vaz,J.A.; Metelko,Z.; Bogoev,M.; Dedov,I. (Diabetes Obes Metab, 2003)